Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Nonalcoholic fatty liver disease (NAFLD) is the principal manifestation of liver disease in obesity and metabolic syndrome. By comparing hypertriglyceridemic transgenic mice expressing apolipoprotein (apo) CIII with control nontransgenic (NTg) littermates, we demonstrated that overexpression of apoCIII, independent of a high-fat diet (HFD), produces NAFLD-like features, including increased liver lipid content; decreased antioxidant power; increased expression of TNF alpha, TNF alpha recep...
Metabolic disorders such as insulin resistance, obesity, and hyperglycemia are prominent risk factor...
Interesterified fats are being widely used by the food industry in an attempt to replace trans fatty...
Nonalcoholic fatty liver disease (NAFLD) encompasses a clinicopathologic spectrum of diseases rangin...
Nonalcoholic fatty liver disease (NAFLD) is the principal manifestation of liver disease in obesity ...
AbstractThe major risk factors for non-alcoholic fatty liver disease (NAFLD) are obesity, insulin re...
Obesity is accompanied by a low-grade inflammation state, characterized by increased proinflammatory...
Nonalcoholic fatty liver disease (NAFLD) and insulin resistance have recently been found to be assoc...
Hypertriglyceridemia is a common type of dyslipidemia found in obesity. However, it is not establish...
Nonalcoholic fatty liver disease (NAFLD) and insulin resistance have recently been found to be assoc...
Non-alcoholic fatty liver disease (NAFLD) defines a spectrum of conditions from simple steatosis to ...
7 p.Nonalcoholic fatty liver disease (NAFLD) is rapidly becoming a world-wide public health problem....
The major risk factors for non-alcoholic fatty liver disease (NAFLD) are obesity, insulin resistance...
The pathogenesis of nonalcoholic fatty liver disease (NAFLD) and the progression to nonalcoholic ste...
Prevalence of obesity and type II diabetes is constantly increasing in industrialized countries. NAF...
Non-Alcoholic Fatty Liver Disease (NAFLD) is caused by the accumulation of fat in over 5% of hepato...
Metabolic disorders such as insulin resistance, obesity, and hyperglycemia are prominent risk factor...
Interesterified fats are being widely used by the food industry in an attempt to replace trans fatty...
Nonalcoholic fatty liver disease (NAFLD) encompasses a clinicopathologic spectrum of diseases rangin...
Nonalcoholic fatty liver disease (NAFLD) is the principal manifestation of liver disease in obesity ...
AbstractThe major risk factors for non-alcoholic fatty liver disease (NAFLD) are obesity, insulin re...
Obesity is accompanied by a low-grade inflammation state, characterized by increased proinflammatory...
Nonalcoholic fatty liver disease (NAFLD) and insulin resistance have recently been found to be assoc...
Hypertriglyceridemia is a common type of dyslipidemia found in obesity. However, it is not establish...
Nonalcoholic fatty liver disease (NAFLD) and insulin resistance have recently been found to be assoc...
Non-alcoholic fatty liver disease (NAFLD) defines a spectrum of conditions from simple steatosis to ...
7 p.Nonalcoholic fatty liver disease (NAFLD) is rapidly becoming a world-wide public health problem....
The major risk factors for non-alcoholic fatty liver disease (NAFLD) are obesity, insulin resistance...
The pathogenesis of nonalcoholic fatty liver disease (NAFLD) and the progression to nonalcoholic ste...
Prevalence of obesity and type II diabetes is constantly increasing in industrialized countries. NAF...
Non-Alcoholic Fatty Liver Disease (NAFLD) is caused by the accumulation of fat in over 5% of hepato...
Metabolic disorders such as insulin resistance, obesity, and hyperglycemia are prominent risk factor...
Interesterified fats are being widely used by the food industry in an attempt to replace trans fatty...
Nonalcoholic fatty liver disease (NAFLD) encompasses a clinicopathologic spectrum of diseases rangin...